Monique Terwijn

1.1k total citations
16 papers, 412 citations indexed

About

Monique Terwijn is a scholar working on Hematology, Immunology and Genetics. According to data from OpenAlex, Monique Terwijn has authored 16 papers receiving a total of 412 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Hematology, 6 papers in Immunology and 5 papers in Genetics. Recurrent topics in Monique Terwijn's work include Acute Myeloid Leukemia Research (14 papers), Chronic Lymphocytic Leukemia Research (4 papers) and Hematopoietic Stem Cell Transplantation (4 papers). Monique Terwijn is often cited by papers focused on Acute Myeloid Leukemia Research (14 papers), Chronic Lymphocytic Leukemia Research (4 papers) and Hematopoietic Stem Cell Transplantation (4 papers). Monique Terwijn collaborates with scholars based in Netherlands, United States and Switzerland. Monique Terwijn's co-authors include Angèle Kelder, Gert J. Ossenkoppele, Sonja Zweegman, Gerrit Jan Schuurhuis, Alexander N. Snel, Anna van Rhenen, Willemijn J. Scholten, Thomas Pabst, Gregor Verhoef and Wendelien Zeijlemaker and has published in prestigious journals such as Blood, PLoS ONE and Cancer Research.

In The Last Decade

Monique Terwijn

15 papers receiving 408 citations

Peers

Monique Terwijn
Alexander N. Snel Netherlands
Juergen Krauter Germany
Wendelien Zeijlemaker Netherlands
Kyle McFarland United States
Antoine Crinquette France
Terrence Bradley United States
Ya‐Zhen Qin China
Sofia von Palffy Sweden
Vaia Stavropoulou Switzerland
Annet Z. Brouwers-Vos Netherlands
Alexander N. Snel Netherlands
Monique Terwijn
Citations per year, relative to Monique Terwijn Monique Terwijn (= 1×) peers Alexander N. Snel

Countries citing papers authored by Monique Terwijn

Since Specialization
Citations

This map shows the geographic impact of Monique Terwijn's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Monique Terwijn with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Monique Terwijn more than expected).

Fields of papers citing papers by Monique Terwijn

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Monique Terwijn. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Monique Terwijn. The network helps show where Monique Terwijn may publish in the future.

Co-authorship network of co-authors of Monique Terwijn

This figure shows the co-authorship network connecting the top 25 collaborators of Monique Terwijn. A scholar is included among the top collaborators of Monique Terwijn based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Monique Terwijn. Monique Terwijn is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
Smit, Marjon A., Fedor Denkers, Monique Terwijn, et al.. (2015). Abstract 2339: IGFBP7 eradicates leukemic stem and progenitor cells in acute myeloid leukemia. Cancer Research. 75(15_Supplement). 2339–2339. 2 indexed citations
2.
Terwijn, Monique, Wendelien Zeijlemaker, Angèle Kelder, et al.. (2014). Leukemic Stem Cell Frequency: A Strong Biomarker for Clinical Outcome in Acute Myeloid Leukemia. PLoS ONE. 9(9). e107587–e107587. 153 indexed citations
3.
Ancker, Willemijn van den, Marvin M. van Luijn, Martine E.D. Chamuleau, et al.. (2014). High class II-associated invariant chain peptide expression on residual leukemic cells is associated with increased relapse risk in acute myeloid leukemia. Leukemia Research. 38(6). 691–693. 10 indexed citations
4.
Schuurhuis, Gerrit Jan, Michaël H. Meel, Monique Terwijn, et al.. (2013). Normal Hematopoietic Stem Cells within the AML Bone Marrow Have a Distinct and Higher ALDH Activity Level than Co-Existing Leukemic Stem Cells. PLoS ONE. 8(11). e78897–e78897. 61 indexed citations
5.
Terwijn, Monique, Angèle Kelder, Alexander N. Snel, et al.. (2012). Minimal residual disease detection defined as the malignant fraction of the total primitive stem cell compartment offers additional prognostic information in acute myeloid leukaemia. International Journal of Laboratory Hematology. 34(4). 432–441. 18 indexed citations
6.
Terwijn, Monique, Angèle Kelder, Alexander N. Snel, et al.. (2010). Accurate Detection of Residual Leukemic Stem Cells In Remission Bone Marrow Predicts Relapse In Acute Myeloid Leukemia Patients. Blood. 116(21). 759–759. 7 indexed citations
7.
Noordhuis, Paul, et al.. (2010). Targeting of CLEC12A In Acute Myeloid Leukemia by Antibody-Drug-Conjugates and Bispecific CLL-1×CD3 BiTE Antibody. Blood. 116(21). 2890–2890. 7 indexed citations
8.
Schuurhuis, Gerrit Jan, Angèle Kelder, Alexander N. Snel, et al.. (2010). Specificity of Markers of Leukemia Initiating Cells with a New Multiparameter Flow Cytometry Based Appraoch; Impact for Prognostic and Therapeutic Applications. Blood. 116(21). 1834–1834. 2 indexed citations
9.
Schuurhuis, Gerrit Jan, Angèle Kelder, Monique Terwijn, et al.. (2010). The Prognostic Value of CD34 Expression In Acute Myeloid Leukemia. A Mystery Solved. Blood. 116(21). 2725–2725. 4 indexed citations
10.
Schuurhuis, G.J., et al.. (2009). Towards Cure of CML: Why We Need to Know More About CML Stem Cells?. Current Stem Cell Research & Therapy. 4(3). 224–236. 1 indexed citations
11.
Terwijn, Monique, N Feller, Anna van Rhenen, et al.. (2009). Interleukin-2 receptor alpha-chain (CD25) expression on leukaemic blasts is predictive for outcome and level of residual disease in AML. European Journal of Cancer. 45(9). 1692–1699. 56 indexed citations
12.
Terwijn, Monique, Angèle Kelder, Alexander N. Snel, et al.. (2009). Leukemic Stem Cell Assessment in Remission Bone Marrow of Acute Myeloid Leukemia Patients Is a New Prognostic Parameter.. Blood. 114(22). 399–399. 5 indexed citations
13.
Janssen, Jeroen J. W. M., Wendy Deenik, Monique Terwijn, et al.. (2009). A New Flowcytometry-Based Method to Discriminate Malignant From Normal Stem Cells in CML.. Blood. 114(22). 3245–3245. 1 indexed citations
14.
15.
16.
Moshaver, Bijan, Anna van Rhenen, Angèle Kelder, et al.. (2008). Identification of a Small Subpopulation of Candidate Leukemia-Initiating Cells in the Side Population of Patients with Acute Myeloid Leukemia. Stem Cells. 26(12). 3059–3067. 83 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Alexander N. Snel Breakdown of academic impact, for papers by Juergen Krauter Breakdown of academic impact, for papers by Wendelien Zeijlemaker Breakdown of academic impact, for papers by Kyle McFarland Breakdown of academic impact, for papers by Antoine Crinquette Breakdown of academic impact, for papers by Terrence Bradley Breakdown of academic impact, for papers by Ya‐Zhen Qin Breakdown of academic impact, for papers by Sofia von Palffy Breakdown of academic impact, for papers by Vaia Stavropoulou Breakdown of academic impact, for papers by Annet Z. Brouwers-Vos
Rankless by CCL
2026